Rising Prevalence of Venous Thromboembolism and Increasing Research Activities are Expected to Drive the Global Heparin Market in the forecast period of 2019 -2026

Global heparin market is projected to register a substantial CAGR of 5.7% in the forecast period of 2019 to 2026. The new market report contains data for the historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Access Full Report at https://databridgemarketresearch.com/reports/global-heparin-market

Drivers: Global Heparin Market

• Rising prevalence of venous thromboembolism and pulmonary embolism
• Increasing research activities

Restraint:

• Increasing government restriction

Opportunity:

• Emerging market

Challenge:

• High competition among players

Market Trends:

Global heparin market is segmented into fourteen notable segments which are product type, mode of administration, source, ingredients, availability, treatment, application, therapeutics, strength, brands, type, container, packaging, end user, distribution channel. 

• On the basis of product type, the market is segmented into unfractionated heparin, low molecular weight heparin (LMWH) and ultra-low molecular weight heparin (ULMWH). The low molecular weight heparin (LMWH) is expected to dominate the global heparin market
• On the basis of mode of administration, the market is segmented into oral administration and parenteral administration
• On the basis of source, the market is segmented into bovine and porcine
• On the basis of ingredients, the market is segmented into sodium and calcium and others
• On the basis of availability, the market is segmented into raw, and processed
• On the basis of treatment, the market is segmented into deep vein thrombosis, pulmonary embolism, arterial thromboembolism and others
• On the basis of application, the market is segmented into pre-surgical procedures, post-surgical procedures, kidney dialysis, diagnostic tests and others
• On the basis of therapeutics, the market is segmented into cardiovascular, respiratory, oncology, nephrology, CNS and others
• On the basis of strength, the market is segmented into 10 unit, 100 unit, 1000 unit, 5000 unit, 10000 unit, 25000 unit and others
• On the basis of type, the market is segmented into generics and brands
• On the basis of container, the market is segmented into bottles, bags, vials and others
• On the basis of packaging, the market is segmented into glass and plastic
• On the basis of end user, the market is segmented into hospitals, clinics, homecare, ambulatory surgical centers and others
• On the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy & drug store, online pharmacy and others

Major Players: Global Heparin Market ​​​​​​​

Some of the major players operating in this market are Sanofi, Pfizer Inc, F. Hoffmann-La Roche Ltd , Mylan N.V., Aspen Holdings, Changzhaou Qianhong Bio-pharma Co., ltd., Eisai Co., Ltd., Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, LEO Pharma A/S, Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., Novartis AG, Opocrin SPA, SARIA SE & Co. KG, Shanghai Fosun Pharmaceutical (Group) Co., Ltd, Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Techdow Pharmaceutical Co., Ltd, Teva Pharmaceutical Industries Ltd., Yino Pharma Limited.